Objective:
The interview discusses Santen’s planned support for the education pillar of WHO’s SPECS 2030 initiative, its priorities in myopia and glaucoma care, and the challenges of translating eye-health evidence and policy into practice.
Approach:
- SPECS 2030 and myopia: Santen plans to support the WHO Foundation partnership on myopia through 2030, including updating the MyopiaEd library and supporting implementation and evaluation in selected countries. WHO leads the program and works with governments, including selecting participating countries.
- Evaluation: Santen plans to define indicators to assess patient outcomes, policy development, decision-making, awareness and behaviors, and the integration of myopia prevention into national health and education plans.
- Other priorities: Santen also aims to support glaucoma-care quality improvement and patient education in Europe and Asia, and to include patient perspectives earlier in research and development, evidence generation, and strategic decision-making.
Key Findings:
- Nakajima identifies four areas for action in myopia: awareness and education, translating evidence into policy and practice, strengthening eye-care professionals’ knowledge and capabilities, and including patient perspectives earlier in research and development.
- School health programs may be explored with national stakeholders as a way to reach children and parents.
- Nakajima describes digital tools as a way to support education and engagement during treatment, and identifies MyopiaEd as a digital education program.
Interpretation:
Santen describes its role as supporting the WHO Foundation partnership on myopia, while WHO leads the program and works with governments. Nakajima says systemic change requires coordinated action and cannot be achieved by one company alone.
Limitations:
- The source is an interview describing company plans and intended indicators; it does not report measured program outcomes.
Conclusion:
Santen’s stated priorities through 2030 include supporting myopia education and implementation, improving glaucoma care, and involving patients earlier in research and decision-making.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.